Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 41 ~ 60 of 25944, Page 3 of 1298
41. Merck to Present New Analyses for JANUVIA (sitagliptin) and STEGLATRO (ertugliflozin), and Real-World Data Studies at the 79th Scientific Sessions of the American Diabetes Association - 05/16/2019
 MERCK
  Real-World Evidence Research to Explore Socioeconomic, Racial and Ethnic Disparities in Diabetes Treatment
42. New ZonePerfect Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results - 05/16/2019
 Abbott
  Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat / ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers
43. Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases - 05/16/2019
 Medtronic
  FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons
44. New Research from Mercks Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting - 05/15/2019
 MERCK
  First-Time Data from POLO Trial Evaluating LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press Program / KEYTRUDA (pembrolizumab) Five-Year Survival Data in Advanced Non-Small Cell Lung Cancer (NSCLC) from KEYNOTE-001 Trial in ASCO Press Program / Overall Survival Data for KEYTRUDA in Metastatic Renal Cell Carcinoma (RCC), Recurrent/Metastatic Head and Neck Cancer and Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer
45. Smarter research & development to tackle global health priorities - 05/15/2019
 WHO
  WHO Chief Scientist invites global health R&D community to contribute to the Directory
46. Nearly 9 out of 10 College Students with Student Debt Say It''s Important to Find a Company That Offers Loan Relief - 05/15/2019
 Abbott
  The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them / Additionally, over 6 in 10 working adults with student loans would consider switching to a company with a student loan employee benefit
47. Current Legal Cannabis Driving Limits in U.S., Europe Are Ineffective According to Breaking Research in AACCs Clinical Chemistry Journal - 05/14/2019
 AACC
  New findings, published today in AACCs Clinical Chemistry journal, add to a growing body of evidence suggesting that no legal driving limit for cannabis can catch impaired recreational users without unfairly penalizing unimpaired regular or medicinal users.
48. Adopting a healthy lifestyle helps reduce the risk of dementia - 05/14/2019
 WHO
  New WHO Guidelines recommend specific interventions for reducing the risk of cognitive decline and dementia
49. Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders - 05/14/2019
 Abbott
  Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies / The BRAIN Initiative brings together the brightest minds across disciplines to improve the treatment and prevention of brain disorders
50. The Academy recognizes 14 health stories with a 2019 Media Orthopaedic Reporting Excellence (MORE) Award - 05/13/2019
 American Academy of Orthopaedic Surgeons
51. Medtronic Reveals Results of First-In-Human Study for Investigational Extravascular ICD System - 05/11/2019
 Medtronic
  Company to Proceed with Plans for Future Pivotal Study of New ICD System
52. WHO is establishing technical advisory group and roster of experts on digital health - 05/10/2019
 WHO
53. Medtronic Enters Into Definitive Agreement to Acquire Titan Spine - 05/09/2019
 Medtronic
  (GLOBE NEWSWIRE via COMTEX) --Acquisition Further Accelerates Medtronic''s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions
54. American Cancer Society Sets Goal to Reduce US Cancer Deaths 40% by 2035 - 05/09/2019
 American Cancer Society
  If people didnt smoke, ate less meat and more fruits and vegetables, exercised more, and followed cancer screening guidelines, the American Cancer Society (ACS) estimates its new challenge goal of reducing cancer deaths by 40% by 2035 could be achieved.
55. Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer - 05/07/2019
 Radiological Society of North America
  A new tool using advanced AI methods can predict a womans future risk of breast cancer. / Researchers used almost 90,000 screening mammograms from about 40,000 women to train, validate and test the new breast cancer risk-assessment model. / The model performs equally well across diverse races, ages and family histories.
56. Worlds First Public Museum Dedicated to Vision Reaches Six-month Milestone - 05/03/2019
 American Academy of Ophthalmology
  With two-thirds of funding goal met, museum set to open in early 2020
57. Death Rates from Liver Cancer Are Increasing, Especially in Men with Less Education - 04/26/2019
 American Cancer Society
  Education Trends in Liver Cancer Death Rates / HCV Infection Trends in Liver Cancer Death Rates
58. RSNA Launches Radiology: Cardiothoracic Imaging - 04/25/2019
 Radiological Society of North America
  The Radiological Society of North America (RSNA) today published the first issue of its new online journal Radiology: Cardiothoracic Imaging.
59. Women with Coronary Artery Wall Thickness at Risk for Heart Disease - 04/25/2019
 Radiological Society of North America
  Researchers used CCTA and Framingham scores to assess coronary artery disease in 62 women and 62 men at low to intermediate risk of heart disease. / Vessel wall thickness, as measured by MRI, was the strongest variable associated with coronary artery disease in women. / The results point to a potential future role for vessel wall thickness measurements in identifying opportunities for early lifestyle changes or treatment.
60. Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA (pembrolizumab) as Monotherapy and in Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma - 04/25/2019
 MERCK
<<  <  [1]  [2]  [3[4]  [5]  [6]  [7]  [8]  [9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com